Literature DB >> 31218904

Can we just kick-and-kill HIV: possible challenges posed by the epigenetically controlled interplay between HIV and host immunity.

Marta Ruiz-Riol1, Christian Brander1,2,3,4.   

Abstract

Entities:  

Keywords:  HIV infection; epigenetics; eradication strategies; host immunity; latent viral reservoir; multilayered-omics analyses; systems vaccinology

Mesh：

Year:  2019        PMID： 31218904      PMCID： PMC6609895          DOI： 10.2217/imt-2019-0092

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  20 in total

1.  Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

Authors:  Beatriz Mothe; Nuria Climent; Montserrat Plana; Miriam Rosàs; José Luis Jiménez; María Ángeles Muñoz-Fernández; María C Puertas; Jorge Carrillo; Nuria Gonzalez; Agathe León; Judit Pich; Joan Albert Arnaiz; Jose M Gatell; Bonaventura Clotet; Julià Blanco; José Alcamí; Javier Martinez-Picado; Carmen Alvarez-Fernández; Sonsoles Sánchez-Palomino; Alberto C Guardo; José Peña; José M Benito; Norma Rallón; Carmen E Gómez; Beatriz Perdiguero; Juan García-Arriaza; Mariano Esteban; Juan Carlos López Bernaldo de Quirós; Christian Brander; Felipe García
Journal:  J Antimicrob Chemother       Date:  2015-02-26       Impact factor: 5.790

Review 2.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

3.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Authors:  Barton F Haynes; Peter B Gilbert; M Juliana McElrath; Susan Zolla-Pazner; Georgia D Tomaras; S Munir Alam; David T Evans; David C Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua-Xin Liao; Anthony L DeVico; George K Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L Robb; Viseth Ngauy; Mark S de Souza; Robert Paris; Guido Ferrari; Robert T Bailer; Kelly A Soderberg; Charla Andrews; Phillip W Berman; Nicole Frahm; Stephen C De Rosa; Michael D Alpert; Nicole L Yates; Xiaoying Shen; Richard A Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L Michael; Jerome H Kim
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

4.  Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.

Authors:  Richard B Pollard; Jürgen K Rockstroh; Giuseppe Pantaleo; David M Asmuth; Barry Peters; Adriano Lazzarin; Felipe Garcia; Kim Ellefsen; Daniel Podzamczer; Jan van Lunzen; Keikawus Arastéh; Dirk Schürmann; Bonaventura Clotet; W David Hardy; Ronald Mitsuyasu; Graeme Moyle; Andreas Plettenberg; Martin Fisher; Gerd Fätkenheuer; Margaret Fischl; Babafemi Taiwo; Ingebjørg Baksaas; Darren Jolliffe; Stefan Persson; Oyvind Jelmert; Arnt-Ove Hovden; Maja A Sommerfelt; Vidar Wendel-Hansen; Birger Sørensen
Journal:  Lancet Infect Dis       Date:  2014-02-11       Impact factor: 25.071

5.  Qualitative host factors associated with immunological control of HIV infection by CD8 T cells.

Authors:  Stephen A Migueles; John C Tilton; Mark Connors
Journal:  Curr Opin HIV AIDS       Date:  2006-01       Impact factor: 4.283

6.  Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.

Authors:  Guido Ferrari; Bette Korber; Nilu Goonetilleke; Michael K P Liu; Emma L Turnbull; Jesus F Salazar-Gonzalez; Natalie Hawkins; Steve Self; Sydeaka Watson; Michael R Betts; Cynthia Gay; Kara McGhee; Pierre Pellegrino; Ian Williams; Georgia D Tomaras; Barton F Haynes; Clive M Gray; Persephone Borrow; Mario Roederer; Andrew J McMichael; Kent J Weinhold
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

7.  Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine.

Authors:  Slim Fourati; Susan Pereira Ribeiro; Filipa Blasco Tavares Pereira Lopes; Aarthi Talla; Francois Lefebvre; Mark Cameron; J Kaewkungwal; P Pitisuttithum; S Nitayaphan; S Rerks-Ngarm; Jerome H Kim; Rasmi Thomas; Peter B Gilbert; Georgia D Tomaras; Richard A Koup; Nelson L Michael; M Juliana McElrath; Raphael Gottardo; Rafick-Pierre Sékaly
Journal:  Nat Commun       Date:  2019-02-20       Impact factor: 14.919

8.  Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.

Authors:  Anni A Winckelmann; Lærke V Munk-Petersen; Thomas A Rasmussen; Jesper Melchjorsen; Thomas J Hjelholt; David Montefiori; Lars Østergaard; Ole S Søgaard; Martin Tolstrup
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

9.  A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects.

Authors:  Ece A Mutlu; Ali Keshavarzian; John Losurdo; Garth Swanson; Basile Siewe; Christopher Forsyth; Audrey French; Patricia Demarais; Yan Sun; Lars Koenig; Stephen Cox; Phillip Engen; Prachi Chakradeo; Rawan Abbasi; Annika Gorenz; Charles Burns; Alan Landay
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

Review 10.  Virological, immune and host genetics markers in the control of HIV infection.

Authors:  Beatriz Mothe; Javier Ibarrondo; Anuska Llano; Christian Brander
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434
View more
  1 in total

1.  In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial.

Authors:  Miriam Rosás-Umbert; Marta Ruiz-Riol; Marco A Fernández; Marta Marszalek; Pep Coll; Christian Manzardo; Samandhy Cedeño; José M Miró; Bonaventura Clotet; Tomáš Hanke; José Moltó; Beatriz Mothe; Christian Brander
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.